SPONSOR
West China Hospital
Total Trials
3
Recruiting
3
Phases
Phase 1, Phase 2, Phase 2, Phase 1
Conditions studied: Anti-PD-1 AntibodyRadiotherapyRectal CancerMSI-HMmr DeficiencyCholangiocarcinomapMMR/MSS Advanced Colorectal Cancer
West China Hospital is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Anti-PD-1 Antibody, Radiotherapy, Rectal Cancer, MSI-H.
The trial portfolio spans Phase 1, Phase 2, Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — West China Hospital
How many clinical trials has West China Hospital sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by West China Hospital, of which 3 are actively recruiting participants. These trials cover conditions including Anti-PD-1 Antibody, Radiotherapy, Rectal Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does West China Hospital research focus on?
West China Hospital clinical trials span Anti-PD-1 Antibody, Radiotherapy, Rectal Cancer, MSI-H, Mmr Deficiency, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a West China Hospital clinical trial?
To participate in a West China Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all West China Hospital trials with current recruitment status updated daily.
Clinical Trials by West China Hospital
NCT04636008 Phase 1, Phase 2
Recruiting
Sintilimab Plus Hypofractionated Radiotherapy for MSI-H/dMMR Rectal Cancer
Anti-PD-1 Antibody
NCT06438822 Phase 2
Recruiting
Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma
Cholangiocarcinoma
NCT07510308 Phase 1
Recruiting
Clinical Study of MSH2-/- Tumor Cell Vaccines for Advanced pMMR Colorectal Cancer Patients
pMMR/MSS Advanced Colorectal Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology